ORKA Q4 2022 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$29,000

Operating Income

-$2M

Net Income

-$1M

EPS (Diluted)

$-0.98

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$43M

Total Liabilities

$1M

Stockholders' Equity

$42M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$29,000	-$28,000	-3.6%
Operating Income	-$2M	-$6M	+72.1%
Net Income	-$1M	-$6M	+79.3%